A differential expression of HuD has been reported in Alzheimer’s disease [8, 9], amyotrophic lateral sclerosis [10], schizophrenia [11], pancreatic neuroendocrine tumor [12], and type 2 diabetes [13]. Here, ELAVL4 is linked to early-onset autosomal dominant Alzheimer disease.